Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Above 50 Day Moving Average – What’s Next?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF)’s stock price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $10.22 and traded as high as $11.19. Ono Pharmaceutical shares last traded at $11.19, with a volume of 4,180 shares traded.

Ono Pharmaceutical Stock Performance

The firm has a fifty day simple moving average of $10.25 and a 200-day simple moving average of $11.62. The company has a current ratio of 3.55, a quick ratio of 2.80 and a debt-to-equity ratio of 0.14. The stock has a market cap of $5.25 billion, a price-to-earnings ratio of 10.75 and a beta of 0.73.

Ono Pharmaceutical (OTCMKTS:OPHLF) last posted its quarterly earnings data on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a return on equity of 9.10% and a net margin of 15.15%.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.